Immediate Impact
95 standout
Citing Papers
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
2023 Standout
Works of Aslı Nar being referenced
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aslı Nar | 383 | 106 | 113 | 148 | 40 | 607 | |
| Berta Soldevila | 270 | 103 | 97 | 105 | 43 | 558 | |
| M. D’Herbomez | 376 | 113 | 170 | 113 | 46 | 672 | |
| Talia Diker‐Cohen | 303 | 57 | 155 | 198 | 39 | 710 | |
| Kyong Yeun Jung | 260 | 72 | 131 | 119 | 36 | 635 | |
| Füsun Saygılı | 313 | 75 | 102 | 139 | 64 | 709 | |
| Wei‐Yih Chiu | 144 | 127 | 81 | 173 | 30 | 572 | |
| Taylan Kabalak | 289 | 73 | 207 | 73 | 30 | 575 | |
| Annalisa Giandalia | 368 | 106 | 137 | 164 | 42 | 682 | |
| Melek Eda Ertörer | 338 | 77 | 130 | 128 | 47 | 701 | |
| Silvia Briganti | 199 | 103 | 167 | 121 | 25 | 636 |
All Works
Login with ORCID to disown or claim papers
Loading papers...